Or click and collect!
Or click and collect!
The cancer risk reduction from stopping smoking is one of the most thoroughly evidenced benefits of cessation, and one of the most motivating. Here is exactly what happens to cancer risk over five, ten and fifteen years of not smoking.
Tobacco smoking is the single largest preventable cause of cancer in the UK. It is causally linked to at least fifteen different cancer types, with lung cancer being the most prominent but far from the only one. The carcinogens in tobacco smoke, more than 70 confirmed carcinogens produced by combustion, accumulate damage in cellular DNA over years of exposure. After quitting, this accumulation stops and the body's DNA repair mechanisms begin working to address the existing damage. The result is a progressive reduction in cancer risk that begins rapidly and continues for decades.
Lung cancer is the cancer most strongly associated with smoking and the one where cessation benefits are most thoroughly documented. After one year without smoking, the excess lung cancer risk from smoking begins falling. After ten years, the risk of dying from lung cancer is approximately half that of a continuing smoker. After fifteen to twenty years, the risk approaches but does not fully reach the level of someone who has never smoked, some accumulated DNA damage cannot be fully repaired, but the risk is dramatically lower than continued smoking would produce.
Cancers of the mouth, throat, larynx and oesophagus are strongly associated with tobacco smoking through direct carcinogen contact with the mucosal lining of these tissues. After quitting, direct carcinogen exposure to these surfaces stops immediately. Risk for these cancers begins declining relatively quickly compared to lung cancer because the exposure pathway is so direct. Significant risk reductions for oral and laryngeal cancers are seen within five years of cessation.
Bladder and kidney cancers are linked to smoking through the concentration and excretion of carcinogens in urine. Bladder epithelium is chronically exposed to concentrated carcinogens in smokers. After quitting, this exposure pathway ceases. Bladder cancer risk falls progressively after cessation, with measurable reductions at five years and continuing beyond.
Smoking is a causal or contributing factor in cancers of the pancreas, stomach, cervix, liver and others. The mechanisms vary by cancer type but all share the common theme of reduced carcinogen exposure after cessation producing progressive risk reduction. The magnitude and timeline of risk reduction varies by cancer type based on the specific exposure mechanism.
The cancer risk reduction from quitting is not simply a matter of stopping the addition of new damage. The body's DNA repair systems, primarily nucleotide excision repair and base excision repair pathways, continue working on the damage already accumulated. Cells with unrepaired carcinogen-induced DNA damage that do not mutate into cancer cells during the repair window are successfully corrected. Over years without new carcinogen exposure, the proportion of cells carrying uncorrected mutagenic damage falls progressively.
"The cancer risk halving at ten years is the statistic that changes how people think about whether it is too late to quit. Ten years is achievable. And at the end of it, your lung cancer risk is half of what it would have been."
Touch of Vape teamSwitching from cigarettes removes the 70-plus combustion carcinogens from your daily exposure from day one. Browse our heavy smoker kits.
Find vape kits designed for heavy smokers ready to make the switch at our best vape for heavy smokers collection.
Our Smoking Cessation guide covers cancer risk, the long-term health benefits of quitting and the complete cessation journey.
Find more cancer risk and cessation guides in our Smoking Cessation guide.
Find your heavy smoker vape kit and begin the journey to a dramatically lower cancer risk.